Evil or Ill? Justifying the Insanity Defense
1999; American Psychiatric Association; Volume: 156; Issue: 10 Linguagem: Inglês
10.1176/ajp.156.10.1659
ISSN1535-7228
Autores Tópico(s)Homicide, Infanticide, and Child Abuse
ResumoBack to table of contents Previous article Next article Book Forum: FORENSIC ISSUESFull AccessEvil or Ill? Justifying the Insanity DefenseGAIL ERLICK ROBINSON, M.D., F.R.C.P.(C), GAIL ERLICK ROBINSON, M.D., F.R.C.P.(C), Toronto, Ont., CanadaPublished Online:1 Oct 1999https://doi.org/10.1176/ajp.156.10.1659AboutSectionsView EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail Jeffrey Dahmer tried to turn victims into sex slaves by injecting acid into their brains, strangled 17 men, had sex with the dead bodies, boiled their skulls, and ate their flesh. Despite this bizarre behavior, a jury did not accept a plea of not guilty by reason of insanity and sentenced him to 957 years in prison. With this anecdote, Lawrie Reznek introduces his philosophical quest to understand the difference between evil and illness, the insanity defense, and the role of psychiatrists in the courts. He examines the standard legal defenses of Durham and M'Naghten as well as that proposed by the American Law Institute. Using a multitude of case examples, he looks at specific excuses (such as automatism and intoxication) presented to the courts and explains how they do or do not fit into the standard defenses. He also distinguishes between legal and medical insanity.This book is not a primer on forensic psychiatry, however. Reznek goes back to his roots as a philosopher to understand why, under certain circumstances, we excuse criminal behavior. He notes that one can perform an evil act such as murder without being an evil person, e.g., in self-defense. He demonstrates that the essential components of most excuses (i.e., that a person is not responsible if he was not in control of his actions or was ignorant of what he was doing) originate in the writings of Aristotle about ignorance and compulsion. Reznek clearly and cogently leads the reader to the conclusion, not previously addressed by philosophers or the law, that our judgment should be based on whether the offender is someone whose actions are consistent with his basically good character. Interestingly, after philosophically arriving at this conclusion, he demonstrates that, despite the legal rules, juries, using "folk psychology," already tend to ascribe responsibility to and punish those with evil characters and excuse good characters.The book is divided into 13 short chapters plus an introduction and a conclusion. Each chapter is subdivided into sections addressing an issue and raising a question to be answered by the next section. Each chapter is succinctly summarized in a paragraph, and the conclusion pulls all of the ideas into a cohesive whole. In attempting to construct this thesis clearly, and perhaps to avoid scaring off readers with "heavy" philosophy, some of the sections seem a little repetitive. However, fascinating case examples and discussions of such issues as multiple personality disorder, the biology of evil, sexual sadism, and psychopathic personality disorder more than compensate. This is a fascinating book that requires us to question our ideas of causality and responsibility. I plan to suggest it to a patient who is still making excuses for abusive parents. I believe this will help her understand that when people choose to act in pursuit of their own selfish interests in a way that is indifferent to others, they are evil characters and are responsible for their behavior. Lawrie Reznek. New York, Routledge, 1998, 329 pp., $75.00; $22.99 (paper). FiguresReferencesCited byDetailsCited byEfficacy, Tolerability, and Acceptance of Long-Lasting Antipsychotics in Children and Adolescents: A Systematic ReviewJournal of Child and Adolescent Psychopharmacology, Vol. 32, No. 6Antipsychotics for negative and positive symptoms of schizophrenia: dose-response meta-analysis of randomized controlled acute phase trials13 September 2021 | npj Schizophrenia, Vol. 7, No. 1Psychodrama for Schizophrenia: adaptive techniques in mutual aid groups27 June 2021 | Social Work with Groups, Vol. 44, No. 3Features of the Interaction of Cognitive Functions with the Work of the Magnocellular and Parvocellular Systems in Patients with Schizophrenia and Endogenous Depression.1 January 2021 | Clinical Psychology and Special Education, Vol. 10, No. 4The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research7 January 2020 | npj Schizophrenia, Vol. 6, No. 1Early treatment response in first episode psychosis: a 7-T magnetic resonance spectroscopic study of glutathione and glutamate24 March 2020 | Molecular Psychiatry, Vol. 25, No. 8Lead-Time Bias Confounds Association Between Duration of Untreated Psychosis and Illness Course in SchizophreniaKatherine G. Jonas, Ph.D., Laura J. Fochtmann, M.D., Greg Perlman, Ph.D., Yuan Tian, M.Sc., John M. Kane, M.D., Evelyn J. Bromet, Ph.D., Roman Kotov, Ph.D.12 February 2020 | American Journal of Psychiatry, Vol. 177, No. 4Cannabis und Schizophrenie – Risikofaktoren, diagnostische Einordnung und Auswirkungen auf Verlauf und Prognose15 May 2019 | Forensische Psychiatrie, Psychologie, Kriminologie, Vol. 13, No. 3Journal of Psychopharmacology, Vol. 33, No. 10Journal of Experimental Psychopathology, Vol. 10, No. 3Personalizing antipsychotic treatment: evidence and thoughts on individualized tailoring of antipsychotic dosage in the treatment of psychotic disorders8 April 2019 | Therapeutic Advances in Psychopharmacology, Vol. 9Rate of and time to symptomatic remission in first-episode psychosis in Northern MalawiMedicine, Vol. 97, No. 45Therapeutic Drug Monitoring of Second-Generation Antipsychotics for the Estimation of Early Drug Effect in First-Episode Psychosis: A Cross-sectional AssessmentTherapeutic Drug Monitoring, Vol. 40, No. 2Molecular Psychiatry, Vol. 23, No. 11International Clinical Psychopharmacology, Vol. 33, No. 3BMC Psychiatry, Vol. 18, No. 1Journal of Korean Neuropsychiatric Association, Vol. 57, No. 3Early Intervention in Psychosis in the United States28 December 2016 | Policy Insights from the Behavioral and Brain Sciences, Vol. 4, No. 1European Archives of Psychiatry and Clinical Neuroscience, Vol. 267, No. 4Expert Opinion on Pharmacotherapy, Vol. 18, No. 4Journal of Psychopharmacology, Vol. 31, No. 12Antipsychotic Response Worsens With Postmenopausal Duration in Women With SchizophreniaJournal of Clinical Psychopharmacology, Vol. 36, No. 6Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug TreatmentDeepak K. Sarpal, M.D., Miklos Argyelan, M.D., Delbert G. Robinson, M.D., Philip R. Szeszko, Ph.D., Katherine H. Karlsgodt, Ph.D., Majnu John, Ph.D., Noah Weissman, B.A., Juan A. Gallego, M.D, M.S., John M. Kane, M.D., Todd Lencz, Ph.D., Anil K. Malhotra, M.D.28 August 2015 | American Journal of Psychiatry, Vol. 173, No. 1CNS Drugs, Vol. 30, No. 10BMC Psychiatry, Vol. 16, No. 1Journal of Korean Neuropsychiatric Association, Vol. 55, No. 4Psychiatrists' awareness of partial- and non-adherence to antipsychotic medication in schizophrenia: results from the Australian ADHES survey17 March 2015 | Australasian Psychiatry, Vol. 23, No. 3European Archives of Psychiatry and Clinical Neuroscience, Vol. 265, No. 7Molecular Psychiatry, Vol. 20, No. 1Serotonin 7 Receptor Variants Are Not Associated with Response to Second-Generation Antipsychotics in Japanese Schizophrenia Patients27 November 2015 | Neuropsychobiology, Vol. 72, No. 2Clinical predictors of therapeutic response to antipsychotics in schizophrenia1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 16, No. 4Psychomotor and cognitive deficits as predictors of 5-year outcome in first-episode schizophrenia20 September 2013 | Nordic Journal of Psychiatry, Vol. 68, No. 4Journal of Medical Economics, Vol. 17, No. 4Should long-acting (depot) antipsychotics be used in early schizophrenia? A systematic review3 December 2012 | Australian & New Zealand Journal of Psychiatry, Vol. 47, No. 7Comparison of Treatment Response in Second-Episode Versus First-Episode SchizophreniaJournal of Clinical Psychopharmacology, Vol. 33, No. 1Psychiatry Investigation, Vol. 10, No. 4Remission in Schizophrenia: Critical and Systematic ReviewHarvard Review of Psychiatry, Vol. 20, No. 6Pharmacogenetics in psychiatry: translating research into clinical practice15 November 2011 | Molecular Psychiatry, Vol. 17, No. 8Psychiatric Quarterly, Vol. 83, No. 3Psychiatry Investigation, Vol. 9, No. 4Clinical Psychopharmacology and Neuroscience, Vol. 10, No. 2Transient Insight Induction With Electroconvulsive Therapy in a Patient With Refractory SchizophreniaThe Journal of ECT, Vol. 27, No. 3Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 13, No. 2Clinical Psychopharmacology and Neuroscience, Vol. 9, No. 2The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia15 June 2010 | BMC Psychiatry, Vol. 10, No. 1Neuropsychopharmacology, Vol. 35, No. 9International Clinical Psychopharmacology, Vol. 25, No. 2International Review of Psychiatry, Vol. 22, No. 5Effect of Treatment on Weight Gain and Metabolic Abnormalities in Patients with First-Episode Psychosis1 January 2009 | Australian & New Zealand Journal of Psychiatry, Vol. 43, No. 9Internal capsule size associated with outcome in first-episode schizophrenia17 February 2009 | European Archives of Psychiatry and Clinical Neuroscience, Vol. 259, No. 5How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials8 January 2008 | Molecular Psychiatry, Vol. 14, No. 4Developing a Risk-Model of Time to First-Relapse for Children and Adolescents With a Psychotic DisorderJournal of Nervous & Mental Disease, Vol. 197, No. 1Early Predictors of Nonadherence to Antipsychotic Therapy in First-Episode Psychosis1 January 2009 | The Canadian Journal of Psychiatry, Vol. 54, No. 1A Review of Second-Generation Antipsychotic Discontinuation in First-Episode PsychosisJournal of Psychiatric Practice, Vol. 14, No. 5Acute Treatment Response and Its Predictors in Patients With First-Episode Psychosis in Iran1 January 2008 | Australasian Psychiatry, Vol. 16, No. 2Association Between Duration of Untreated Psychosis, Premorbid Functioning, and Cognitive Performance and the Outcome of First-Episode Schizophrenia in Japanese Patients: Prospective Study1 January 2008 | Australian & New Zealand Journal of Psychiatry, Vol. 42, No. 2Predictors of Antipsychotic-Induced Weight Gain in First-Episode PsychosisJournal of Clinical Psychopharmacology, Vol. 28, No. 1Journal of Clinical Psychopharmacology, Vol. 28, No. 2International Clinical Psychopharmacology, Vol. 23, No. 6Early Intervention in Psychiatry, Vol. 2, No. 2Psychopathology, Vol. 41, No. 2Expert Opinion on Pharmacotherapy, Vol. 9, No. 12Journal of Korean Medical Science, Vol. 23, No. 4Psychiatry Investigation, Vol. 5, No. 2Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week ComparisonJoseph P. McEvoy, M.D.Jeffrey A. Lieberman, M.D.Diana O. Perkins, M.D., M.P.H.Robert M. Hamer, Ph.D.Hongbin Gu, Ph.D.Arthur Lazarus, M.D., M.B.A.Dennis Sweitzer, Ph.D.Christina OlexyPeter Weiden, M.D.Stephen D. Strakowski, M.D.1 July 2007 | American Journal of Psychiatry, Vol. 164, No. 7Pharmacoepidemiology and Drug Safety, Vol. 16, No. 7Psychiatrie und Psychotherapie, Vol. 3, No. 1Early Intervention in Psychiatry, Vol. 1, No. 3The Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry, Vol. 35, No. 2Time Course for Antipsychotic Treatment Response in First-Episode SchizophreniaRobin Emsley, M.D.Jonathan Rabinowitz, Ph.D.Rossella Medori, M.D.1 April 2006 | American Journal of Psychiatry, Vol. 163, No. 4Prognostic Variables at Intake and Long-Term Level of Function in SchizophreniaSteven J. Siegel, M.D., Ph.D., Farzin Irani, M.S., Colleen M. Brensinger, M.S., Christian G. Kohler, M.D., Warren B. Bilker, Ph.D., J. Daniel Ragland, Ph.D., Stephen J. Kanes, M.D., Ph.D., Ruben C. Gur, Ph.D., and Raquel E. Gur, M.D., Ph.D.1 March 2006 | American Journal of Psychiatry, Vol. 163, No. 3Psychopharmacology, Vol. 187, No. 3Journal of Clinical and Experimental Neuropsychology, Vol. 28, No. 2Journal of Women's Health, Vol. 15, No. 10Acta Psychiatrica Scandinavica, Vol. 113, No. 4Relationship Between Duration of Untreated Psychosis and Outcome in First-Episode Schizophrenia: A Critical Review and Meta-AnalysisDiana O. Perkins, M.D., M.P.H., Hongbin Gu, Ph.D., Kalina Boteva, M.D., and Jeffrey A. Lieberman, M.D.1 October 2005 | American Journal of Psychiatry, Vol. 162, No. 10Treatment of Cognitive Impairment in Early Psychosis: A Comparison of Risperidone and Haloperidol in a Large Long-Term TrialPhilip D. Harvey, Ph.D., Jonathan Rabinowitz, Ph.D., Marielle Eerdekens, M.D., and Michael Davidson, M.D.1 October 2005 | American Journal of Psychiatry, Vol. 162, No. 10Duration of Untreated Psychosis and Time to Treatment Response for Delusions and HallucinationsHandan Gunduz-Bruce, M.D., Marjorie McMeniman, Ph.D., Delbert G. Robinson, M.D., Margaret G. Woerner, Ph.D., John M. Kane, M.D., Nina R. Schooler, Ph.D., and Jeffrey A. Lieberman, M.D.1 October 2005 | American Journal of Psychiatry, Vol. 162, No. 10Risperidone and Haloperidol in First-Episode Psychosis: A Long-Term Randomized TrialNina Schooler, Ph.D., Jonathan Rabinowitz, Ph.D., Michael Davidson, M.D., Robin Emsley, M.D., Philip D. Harvey, Ph.D., Lili Kopala, M.D., Patrick D. McGorry, M.D., Ilse Van Hove, M.Sc., Marielle Eerdekens, M.D., Wim Swyzen, M.D., and Goedele De Smedt, M.D., 1 May 2005 | American Journal of Psychiatry, Vol. 162, No. 5Treating early psychosis: who, what, and when?1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 7, No. 1PSN, Vol. 3, No. S1International Journal of Psychiatry in Clinical Practice, Vol. 9, No. 4International Journal of Psychiatry in Clinical Practice, Vol. 9, No. 2The World Journal of Biological Psychiatry, Vol. 6, No. 3Journal of Child and Adolescent Psychopharmacology, Vol. 15, No. 2Journal of Child and Adolescent Psychopharmacology, Vol. 15, No. 3International Clinical Psychopharmacology, Vol. 20, No. 4Journal of Psychiatric Practice, Vol. 11, No. 3Acta Psychiatrica Scandinavica, Vol. 111, No. 3Psychotic Disorders Clinic and First-Episode Psychosis: A Program Evaluation1 January 2005 | The Canadian Journal of Psychiatry, Vol. 50, No. 1Bulletin of the Menninger Clinic, Vol. 69, No. 3Gender Differences in the Prescribing of Antipsychotic DrugsMary V. Seeman, M.D.1 August 2004 | American Journal of Psychiatry, Vol. 161, No. 8Treatment-refractory schizophrenia1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 6, No. 1Sex-dependent modulation of treatment response1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 6, No. 1Symptomatic and Functional Recovery From a First Episode of Schizophrenia or Schizoaffective DisorderDelbert G. Robinson, M.D., Margaret G. Woerner, Ph.D., Marjorie McMeniman, Ph.D., M.S., Alan Mendelowitz, M.D., and Robert M. Bilder, Ph.D.1 March 2004 | American Journal of Psychiatry, Vol. 161, No. 3International Journal of Methods in Psychiatric Research, Vol. 13, No. 1Journal of Psychiatric Practice, Vol. 10, No. 5Removing Barriers to Treatment of First-Episode Psychotic Disorders1 October 2003 | The Canadian Journal of Psychiatry, Vol. 48, No. 8Comparative Efficacy and Safety of Atypical and Conventional Antipsychotic Drugs in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus HaloperidolJeffrey A. Lieberman, M.D., Gary Tollefson, M.D., Ph.D., Mauricio Tohen, M.D., Dr.P.H., Alan I. Green, M.D., Raquel E. Gur, M.D., Ph.D., Rene Kahn, M.D., Ph.D., Joseph McEvoy, M.D., Diana Perkins, M.D., M.P.H., Tonmoy Sharma, M.D., Robert Zipursky, M.D., Hank Wei, Ph.D., Robert M. Hamer, Ph.D., and 1 August 2003 | American Journal of Psychiatry, Vol. 160, No. 8Clozapine as a First Treatment for SchizophreniaMargaret G. Woerner, Ph.D., Delbert G. Robinson, M.D., Jose Ma. J. Alvir, Dr.P.H., Brian B. Sheitman, M.D., Jeffrey A. Lieberman, M.D., and John M. Kane, M.D.1 August 2003 | American Journal of Psychiatry, Vol. 160, No. 8Early Intervention in Psychosis: An Overdue Reform17 November 2016 | Australian & New Zealand Journal of Psychiatry, Vol. 37, No. 4Summary Australian and New Zealand Clinical Practice Guideline for the Treatment of Schizophrenia 200316 November 2016 | Australasian Psychiatry, Vol. 11, No. 2Bouffée Délirante and ICD-10 Acute and Transient Psychoses: A Comparative Study17 November 2016 | Australian & New Zealand Journal of Psychiatry, Vol. 37, No. 3Neuropsychopharmacology, Vol. 28, No. 5Current Opinion in Psychiatry, Vol. 16Current Opinion in Psychiatry, Vol. 16, No. 6Expert Opinion on Pharmacotherapy, Vol. 4, No. 5Drugs, Vol. 63, No. 21Early Psychosis intervention by a community mental health team25 June 2016 | Australasian Psychiatry, Vol. 10, No. 3Status of Patients With First-Episode Psychosis After One Year of Phase-Specific Community-Oriented TreatmentAshok K. Malla, M.B.B.S., F.R.C.P.(C.), Ross M. G. Norman, Ph.D., C.Psych., Rahul Manchanda, M.D., F.R.C.P.(C.), Terry S. McLean, R.N., M.Ed., Raj Harricharan, M.B.B.S., F.R.C.P.(C.), Leonardo Cortese, M.D., F.R.C.P.(C.), Laurel A. Townsend, Ph.D., C.Psych., and Derek J. Scholten, M.Sc.1 April 2002 | Psychiatric Services, Vol. 53, No. 4Neuropsychological Correlates of Hippocampal Volumes in Patients Experiencing a First Episode of SchizophreniaPhilip R. Szeszko, Ph.D., Rael D. Strous, M.D., Robert S. Goldman, Ph.D., Manzar Ashtari, Ph.D., Kevin H. Knuth, Ph.D., Jeffrey A. Lieberman, M.D., and Robert M. Bilder, Ph.D.1 February 2002 | American Journal of Psychiatry, Vol. 159, No. 2Journal of Clinical Psychopharmacology, Vol. 22, No. 4Current Medical Research and Opinion, Vol. 18, No. sup3First-Episode Psychosis in the Military: A Comparative Study of Prodromal Symptoms17 November 2016 | Australian & New Zealand Journal of Psychiatry, Vol. 35, No. 4Early detection and intervention in first-episode schizophrenia: a critical review20 December 2001 | Acta Psychiatrica Scandinavica, Vol. 103, No. 5Disease Management and Health Outcomes, Vol. 9, No. 6A public health approach to clinical therapeutics in psychiatry: directions for new research1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 2, No. 3Neuropsychology of First-Episode Schizophrenia: Initial Characterization and Clinical CorrelatesRobert M. Bilder, Ph.D., Robert S. Goldman, Ph.D., Delbert Robinson, M.D., Gail Reiter, M.S., Lisa Bell, Ph.D., John A. Bates, M.S., Elizabeth Pappadopulos, Ph.D., Deborah F. Willson, Ph.D., Jose Maria J. Alvir, Dr.P.H., Margaret G. Woerner, Ph.D., Stephen Geisler, M.D., John M. Kane, M.D., and Jeffrey A. Lieberman, M.D.1 April 2000 | American Journal of Psychiatry, Vol. 157, No. 4Current Opinion in Psychiatry, Vol. 13, No. 1 Volume 156Issue 10 October 1999Pages 1659-1659 Metrics History Published online 1 October 1999 Published in print 1 October 1999
Referência(s)